While the broader market remains volatile, the top 1% of Wall Street analysts are focusing on a few specific names. Using TipRanks’ Analyst Top Stocks tool, we have identified three companies that have received unanimous support from the Street’s best-performing experts today.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Here are today’s top stock picks for your portfolio.
- Aclaris Therapeutics (ACRS) – Aclaris Therapeutics is a biotech company focused on developing treatments for immuno-inflammatory diseases. Today, Oppenheimer analyst Jeff Jones maintained a Buy rating on the stock with a price target of $10 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 179.90%.
- KalVista Pharmaceuticals (KALV) – KalVista Pharmaceuticals is a biotech company developing treatments for rare diseases. Today, Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on the stock with a price target of $32 per share. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 70.52%.
- Meta Platforms (META) – Meta Platforms is a social media and technology company focused on digital advertising and virtual reality. Today, investment bank TD Cowen analyst John Blackledge maintained a Buy rating on the stock with a price target of $820 per share. Interestingly, 39 out of the 45 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 27.38%.